Comprehensive Eylea Market Analysis 2024: Size, Share, And Key Trends
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate Can Be Expected in the Eylea Market from 2024 Through 2033?
Over the past few years, the eylea market has witnessed significant growth. It is projected to escalate from $7.8 billion in 2023 to $8.19 billion in 2024, with a compound annual growth rate (CAGR) of 5.1%. Factors contributing to this growth throughout the historical period include the prevalence of diabetic macular edema (dme), clinical efficiency and safety profile, competition with other anti-vegf therapies, approvals for treating various retinal conditions, and a shift towards intravitreal injections.
In the upcomming years, the Eylea market size is predicted to experience robust growth. An increase in its value to $10.16 billion by 2028 is expected, with a compound annual growth rate (CAGR) of 5.5%. Emerging therapeutic indications, biosimilar competition inception, enhanced awareness and diagnosis, as well as post-market studies and real-world evidence, along with patients favoring less frequent injections, account for this growth in the forecast period. The forecast period also foresees key trends, such as improvements in imaging technologies, the rise of telemedicine and remote patient monitoring, patient assistance schemes, advancements in drug delivery technologies, retinal imaging technologies, and clinical trials for fresh indications.
Claim Your Free Sample of the Global Eylea Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9155&type=smp
What Dynamics Are Shaping the Growth of the eylea Market?
The Eylea market is expected to be propelled by the escalating rates of eye-related diseases. Diseases of the eye that hamper its normal functioning and decrease the clarity of sight are categorized as ocular diseases, which often progress unnoticed until they reach an advanced stage. Wet age-related macular degeneration (AMD) and glaucoma are among the ocular diseases for which Eylea is an effective treatment. These diseases impair vision by damaging the retina or macula. The role of Eylea is to block the protein that creates new but weaker blood vessels, and it also reduces swelling of the retina caused by a blockage in the blood vessels. As underscored by data from the US-based nonprofit, BrightFocus Foundation, in October 2022, glaucoma affected 80 million people worldwide. This number is projected to swell to over 111 million by 2040. Thus, the escalating occurrence of ocular diseases is catalyzing the growth of the Eylea market.
What Are the Essential Segments of the Eylea Market?
1) By Product: Prefilled Syringe Package, Vial Package
2) By Disorder: Wet Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Other Disorders
3) By Application: Hospitals, Retail Pharmacy, Other Applications
What Are the Defining Trends in the Evolving Eylea Market?
The eylea market is seeing a notable trend in the emphasis on research and development. Leading entities within the industry are prioritizing innovative technical solutions. An example of this is seen in the actions of Regeneron Pharmaceuticals, Inc., a globally recognized biotech company based in the US that develops treatments for serious illnesses. In August 2023, the company gained US FDA approval for Eylea HD (aflibercept) injection 8 mg. This product is designed to target patients suffering from wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and diabetic retinopathy (DR). The application regimen is set to begin with a period of every four weeks for the three initial months across all indications. Thereafter, the intervals are adjusted to every eight to 16 weeks for wAMD and DME, and every eight to 12 weeks for diabetic retinopathy.
Order Now for Fast Delivery of Your Eylea Market Report!
https://www.thebusinessresearchcompany.com/report/eylea-global-market-report
Which Regions Are Emerging as Leaders in the Eylea Market?
North America was the largest region in the eylea market in 2023. Asia-Pacific is expected to be the fastest-growing region in the eylea market during the forecast period. The regions covered in the eylea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Eylea Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the eylea market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Eylea Market Include
1. Eylea Market Executive Summary
2. Eylea Market Segments
3. Eylea Market Size And Template Market Growth Rate
4. Key Eylea Market Trends
5. Major Eylea Market Drivers
……
25. Key Mergers And Acquisitions In The Eylea Market
26. Top Eylea Companies
27. Eylea Market Opportunities And Strategies
28. Eylea Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: